Fasted Bioavailability Study of Cilostazol Tablets, 100 mg
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate and compare the relative bioavailability of a test
formulation of cilostazol tablets to an equivalent dose of Pletal® (cilostazol) tablets after
a single oral dose administered under fasting conditions.